Callan JMB Inc. (CJMB)
| Market Cap | 13.92M -25.8% |
| Revenue (ttm) | 5.09M -13.8% |
| Net Income | -9.77M |
| EPS | -1.93 |
| Shares Out | 5.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 115,478 |
| Open | 2.110 |
| Previous Close | 2.170 |
| Day's Range | 1.950 - 2.420 |
| 52-Week Range | 0.650 - 5.610 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About CJMB
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, whi... [Read more]
Financial Performance
In 2025, Callan JMB's revenue was $5.72 million, a decrease of -12.80% compared to the previous year's $6.56 million. Losses were -$7.97 million, 247.3% more than in 2024.
Financial StatementsNews
Callan JMB Advances U.S. Pharmaceutical Manufacturing at the Atlas Complex and Expands into North American Equipment Distribution and Assembly
Approximately $28 million in planned TRUKING equipment advances domestic manufacturing capacity, strengthens the Company's preparedness strategy, and supports new commercial opportunities
Callan Power to Acquire Williston Basin Non-Operated Oil and Gas Assets with $48 Million Proved PV-10 and $83 Million 3P PV-10 from The Pfanenstiel Company, Significantly Expanding Energy Assets
Acquisition includes interests across 377 producing wells, approximately 150 BOE/day of current net production, and 27 additional wells in process, with $48 million of proved PV-10 and an illustrative...
Callan JMB Designates Andy Weigman to Join Callan Power's Oil and Gas Development Efforts; Weigman Brings Experience on More Than $1 Billion in Sourced Acquisition Opportunities and Extensive Williston Basin Operational Expertise
Weigman brings 14 years of Williston Basin experience, including nine years at Northern Oil and Gas, and has sourced potential acquisition opportunities across more than 900 wells The appointment will...
Callan JMB Retains Northern Oil and Gas Founder Michael Reger as President of Callan Power; Northern Oil and Gas Now Valued at Approximately $2.9 Billion
Mr. Reger brings proven public-company, capital-markets, and energy-sector leadership to advance Callan Power's domestic manufacturing and critical electrical-infrastructure strategy
Callan JMB's Callan Power to Acquire Reger Oil Assets in The Williston Basin; Northern Oil and Gas Former CEO and Founder Michael Reger Named President of Callan Power and Board Member
Program projected to generate approximately $252 million in cumulative net operating cash flow 23-well Red River drilling program forecast to achieve positive operating cash flow in its first year of ...
Callan JMB regains compliance with Nasdaq
Callan JMB (CJMB) announced that on August 14, it received written notification from Nasdaq confirming that the company has regained compliance with Nasdaq Listing Rule 5550, which requires listed sec...
Callan JMB Inc. Regains Compliance with Nasdaq's Minimum Bid Price Requirement
SPRING BRANCH, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (“Callan JMB” or the “Company”) (Nasdaq: CJMB) a diversified company focused on logistics, emergency preparedness and critical i...
Callan JMB announces $60M joint venture in Alabama
Callan JMB (CJMB), Bia Power Systems and Alabama State University announced a strategic joint venture to establish an advanced transformer and electrical-equipment manufacturing and assembly operation...
Callan JMB Continues Longstanding Emergency Preparedness Support for the City of Chicago During Lollapalooza Weekend
Company builds on its history of supporting Chicago's preparedness operations during major public events and periods of heightened citywide activity
Callan JMB Expands Atlas Complex, Advances Recurring Infrastructure Services Business with Cavalry 1838 Equine Biosciences
Agreement reinforces the Atlas Complex strategy while expanding Callan JMB's recurring infrastructure services business through a 60% participation in enterprise revenue. The enterprise's underlying b...
Callan JMB and Alabama State University Break Ground on Atlas Complex, Launching an Unprecedented Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
This new landmark project is forecast to ultimately generate estimated annual gross revenues of $500 million for the partnership Callan JMB is entitled to receive a 21% participation in the venture, w...
Callan JMB partners with Alabama State University on drug manufacturing
Callan JMB (CJMB) announced a strategic partnership with Alabama State University to support the development of an integrated pharmaceutical manufacturing ecosystem designed to strengthen domestic pha...
Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosyste...
Callan JMB announces strategic partnership with Alabama State University
Callan JMB (CJMB) announced a strategic partnership with Alabama State University to support workforce development, applied research, and industry collaboration at Atlas Complex by Callan JMB. The col...
Callan JMB Inc. and Alabama State University Partner to Advance Workforce Development, Research, and Pharmaceutical Innovation at the Atlas Complex
Strategic partnership integrates higher education, industry, and workforce development to accelerate pharmaceutical onshoring and strengthen domestic supply chains
Callan JMB Expands Oregon Public Health Support Capabilities Through State VFC Authorization
Approval enhances the Company's ability to receive, prepare, and deploy pediatric-focused medical materials in support of state and local public health initiatives
Callan JMB files $250M mixed securities shelf
17:31 EDT Callan JMB (CJMB) files $250M mixed securities shelf
Callan JMB expands $175,000 per month infrastructure engagement
Callan JMB (CJMB) announced the expansion and extension of an existing long-term public sector infrastructure engagement valued at approximately $175,000 per month over the next six months. The agreem...
Callan JMB Expands Long-Standing Public Sector Infrastructure Engagement
Strategic extension reinforces recurring revenue visibility and growing demand for preparedness, continuity, and cold chain infrastructure Spring Branch, TX, May 20, 2026 (GLOBE NEWSWIRE) -- Callan JM...
Callan JMB announces The Atlas Complex in Alabama
Callan JMB (CJMB) announced Atlas Complex by Callan JMB, a planned 150 acre campus in Marion, Alabama designed to support an increase of pharmaceutical onshoring, medical logistics, and domestic suppl...
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency ...
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network
Callan JMB to provide oversight for JKB-122 manufacturing scale-up
Callan JMB (CJMB) announced its role as an independent infrastructure and oversight partner in a collaboration led by DifGen Pharmaceuticals and Aveva Drug Delivery Systems, alongside Biostax Corp and...
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications
Callan JMB, Attune Biotech partner for clinical trials for lodonal
Callan JMB (CJMB) has agreed with Biostax Corp d/b/a Attune Biotech to support its investigational new drug clinical trials for the treatment of Post-Acute Sequelae of SARS-CoV-2 infection, commonly k...